Retraction notices

Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway

Type
Retraction
Notice date
9/29/2023 0:00
Journal
Stem Cell Research & Therapy
Publisher
Springer - Biomed Central (BMC)
Notice DOI
10.1186/s13287-023-03513-2
Original paper DOI
10.1186/s13287-018-0771-y

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.